ZLD 8.11% 80.0¢ zelira therapeutics limited

Dave all phara products take years and expense to get to market....

  1. 4,350 Posts.
    lightbulb Created with Sketch. 2033
    Dave all phara products take years and expense to get to market. But tradiitionally they dont make any revenue along the pathway to regulation. ZLD investor presentations show this clearly.

    ZLD products are whole of plant products. Very few in that space. And this along with clinical testing are huge difference makers from any generic CBD oil.

    ZLD is doing exactly what it has been saying it will be doing. Worldwide, opinions toward medical cannabis are finally changing. Yes they need more licensing deals. Yes we need more updates on Pain and Parkinson products. And yes we need clearer communication in company communications. But the fundamentals are probably stronger now than they have ever been.
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
(20min delay)
Last
80.0¢
Change
0.060(8.11%)
Mkt cap ! $8.396M
Open High Low Value Volume
80.0¢ 80.0¢ 80.0¢ $4.4K 5.5K

Buyers (Bids)

No. Vol. Price($)
1 680 75.0¢
 

Sellers (Offers)

Price($) Vol. No.
79.0¢ 1429 1
View Market Depth
Last trade - 10.09am 22/08/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.